These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35976880)

  • 1. Targeting of microvillus protein Eps8 by the NleH effector kinases from enteropathogenic
    Pollock GL; Grishin AM; Giogha C; Gan J; Oates CV; McMillan PJ; Gaeta I; Tyska MJ; Pearson JS; Scott NE; Cygler M; Hartland EL
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2204332119. PubMed ID: 35976880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function.
    Gao X; Wan F; Mateo K; Callegari E; Wang D; Deng W; Puente J; Li F; Chaussee MS; Finlay BB; Lenardo MJ; Hardwidge PR
    PLoS Pathog; 2009 Dec; 5(12):e1000708. PubMed ID: 20041225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2.
    Pham TH; Gao X; Tsai K; Olsen R; Wan F; Hardwidge PR
    Infect Immun; 2012 Jun; 80(6):2133-40. PubMed ID: 22451523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteropathogenic E. coli non-LEE encoded effectors NleH1 and NleH2 attenuate NF-κB activation.
    Royan SV; Jones RM; Koutsouris A; Roxas JL; Falzari K; Weflen AW; Kim A; Bellmeyer A; Turner JR; Neish AS; Rhee KJ; Viswanathan VK; Hecht GA
    Mol Microbiol; 2010 Dec; 78(5):1232-45. PubMed ID: 21091507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EPEC NleH1 is significantly more effective in reversing colitis and reducing mortality than NleH2 via differential effects on host signaling pathways.
    Kralicek SE; Nguyen M; Rhee KJ; Tapia R; Hecht G
    Lab Invest; 2018 Apr; 98(4):477-488. PubMed ID: 29396422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nck adaptors, besides promoting N-WASP mediated actin-nucleation activity at pedestals, influence the cellular levels of enteropathogenic Escherichia coli Tir effector.
    Nieto-Pelegrin E; Kenny B; Martinez-Quiles N
    Cell Adh Migr; 2014; 8(4):404-17. PubMed ID: 25482634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding specificity of type three secretion system effector NleH2 to multi-cargo chaperone CesT and their phosphorylation.
    Yadav M; Srinivasan M; Tulsian NK; Liu YX; Lin Q; Rosenshine I; Sivaraman J
    Protein Sci; 2021 Dec; 30(12):2433-2444. PubMed ID: 34662450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EspFu-Mediated Actin Assembly Enhances Enteropathogenic
    Martins FH; Kumar A; Abe CM; Carvalho E; Nishiyama-Jr M; Xing C; Sperandio V; Elias WP
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding to Na(+) /H(+) exchanger regulatory factor 2 (NHERF2) affects trafficking and function of the enteropathogenic Escherichia coli type III secretion system effectors Map, EspI and NleH.
    Martinez E; Schroeder GN; Berger CN; Lee SF; Robinson KS; Badea L; Simpson N; Hall RA; Hartland EL; Crepin VF; Frankel G
    Cell Microbiol; 2010 Dec; 12(12):1718-31. PubMed ID: 20618342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.
    Wong AR; Pearson JS; Bright MD; Munera D; Robinson KS; Lee SF; Frankel G; Hartland EL
    Mol Microbiol; 2011 Jun; 80(6):1420-38. PubMed ID: 21488979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli virulence protein NleH1 interaction with the v-Crk sarcoma virus CT10 oncogene-like protein (CRKL) governs NleH1 inhibition of the ribosomal protein S3 (RPS3)/nuclear factor κB (NF-κB) pathway.
    Pham TH; Gao X; Singh G; Hardwidge PR
    J Biol Chem; 2013 Nov; 288(48):34567-74. PubMed ID: 24145029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type III effector NleH2 from Escherichia coli O157:H7 str. Sakai features an atypical protein kinase domain.
    Halavaty AS; Anderson SM; Wawrzak Z; Kudritska M; Skarina T; Anderson WF; Savchenko A
    Biochemistry; 2014 Apr; 53(15):2433-5. PubMed ID: 24712300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Host Proteins and Signaling Pathways in Enteropathogenic E. coli Pathogenesis Identified by Global Phosphoproteome Analysis.
    Scholz R; Imami K; Scott NE; Trimble WS; Foster LJ; Finlay BB
    Mol Cell Proteomics; 2015 Jul; 14(7):1927-45. PubMed ID: 25944883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling.
    Shames SR; Deng W; Guttman JA; de Hoog CL; Li Y; Hardwidge PR; Sham HP; Vallance BA; Foster LJ; Finlay BB
    Cell Microbiol; 2010 Sep; 12(9):1322-39. PubMed ID: 20374249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.
    Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G
    mBio; 2012; 3(5):. PubMed ID: 23033475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function.
    Iizumi Y; Sagara H; Kabe Y; Azuma M; Kume K; Ogawa M; Nagai T; Gillespie PG; Sasakawa C; Handa H
    Cell Host Microbe; 2007 Dec; 2(6):383-92. PubMed ID: 18078690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.
    Sham HP; Shames SR; Croxen MA; Ma C; Chan JM; Khan MA; Wickham ME; Deng W; Finlay BB; Vallance BA
    Infect Immun; 2011 Sep; 79(9):3552-62. PubMed ID: 21746856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling of infection by enteropathogenic Escherichia coli strains in lineages 2 and 4 ex vivo and in vivo by using Citrobacter rodentium expressing TccP.
    Girard F; Crepin VF; Frankel G
    Infect Immun; 2009 Apr; 77(4):1304-14. PubMed ID: 19188355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and regulation of the Escherichia coli O157:H7 effector proteins NleH1 and NleH2.
    Holmes A; Lindestam Arlehamn CS; Wang D; Mitchell TJ; Evans TJ; Roe AJ
    PLoS One; 2012; 7(3):e33408. PubMed ID: 22428045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of enteropathogenic Escherichia coli map is significantly different than that of other type III secreted effectors in vivo.
    Nguyen M; Rizvi J; Hecht G
    Infect Immun; 2015 Jan; 83(1):130-7. PubMed ID: 25312947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.